Cataract surgery. Cataract surgery
Conditions
Interventions
Intervention 1: Intervention group: patients in group (E )received 0.1 mg/kg etomidate. In case of need, 4 mg etomidate will be injected as a rescue dose. At the end of the prescribed total dose is re
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 85 Years
Inclusion criteria
Inclusion criteria: Patients who are candidates for Phacoemulsification cataract surgery Patients who are satisfied to enter the study Patients aged 35-85 years old patients with ASA class 1 and 2
Exclusion criteria
Exclusion criteria: History of any allergy or allergic reaction to any of medications used in the study History of head injury High intraocular pressure or intracranial pressure Cardiovascular risk Hypertension Severe respiratory disease Advanced liver disease Epilepsy or history of seizure Nervous system disorders The presence of any tumor or brain metastasis Use of any analgesic and anesthetic drugs Chronic pain syndroms Patients who are not satisfied to enter the study Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation level. Timepoint: After induction of anesthesia, during the procedure every 5 minutes. Method of measurement: Modified ramsay sedation scale (RSS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean Atrial Pressure. Timepoint: Before surgery, every 5 minutes during surgery and after the surgery every 10 minutes for 30 minutes in recovery. Method of measurement: Pressure gauge.;Oxygen saturation percentage. Timepoint: Before surgery, every 5 minutes during surgery and after the surgery every 10 minutes for 30 minutes in recovery. Method of measurement: Pulse oximetry.;Heart rate. Timepoint: Before surgery, every 5 minutes during surgery and after the surgery every 10 minutes for 30 minutes in recovery. Method of measurement: Pulse oximetry.;Adverse drug reaction. Timepoint: Before surgery, every 5 minutes during surgery and after the surgery every 10 minutes for 30 minutes in recovery. Method of measurement: Adverse drug reaction questionnaire.;Recovery time. Timepoint: From the end of the surgery to the time exit Recovery. Method of measurement: Minute.;Surgeon satisfaction. Timepoint: End of surgery. Method of measurement: Likert scale.;Patient satisfaction. Timepoint: End of Recovery. Method of measurement: Likert scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactIsfahan University of Medical Sciences
Esfahan University of Medical Sciences
Outcome results
None listed